After promising trial results for maternal RSV vaccine, Pfizer says it will seek FDA approval this year
By Brenda Goodman, CNN Pfizer says it has enough promising data on its respiratory syncytial virus, or RSV, vaccine designed to protect newborns that…
Continue Reading